ClinicalTrials.Veeva

Menu

Postoperative Therapy After Interposition Arthroplasty in CMC1

D

Diakonhjemmet Hospital

Status

Unknown

Conditions

Thumb Osteoarthritis

Treatments

Other: Early mobilisation after CMC1-surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT01679717
H4/2012

Details and patient eligibility

About

In this randomized controlled trial the investigators want to investigate whether early versus late mobilisation after surgery in the first carpometacarpal joint (CMC1) leads to a faster recovery of hand function. The investigators also want to explore patients' satisfaction with the two different treatment regimes. The participants in the control group will receive the standard treatment at Diakonhjemmet hospital: immobilisation of the thumb in a splint for six weeks. The participants in the intervention group will use a soft splint for six weeks, but will be instructed to remove the splint daily to perform exercises for the thumb. A total of 70 patients will be included in the study.

Enrollment

70 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Osteoarthritis in CMC1 diagnosed by radiography and a surgeon.
  • Planned surgery(interposition arthroplasty) in CMC1
  • Ability to communicate in Norwegian

Exclusion criteria

  • Surgery involving other joints of the hand in addition to CMC1.
  • Previous surgery of the same thumb.
  • Other diseases og injuries that could influence hand function.
  • Mental or cognitive deficit.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Early mobilisation after CMC1-surgery
Active Comparator group
Description:
Mobilisation at two weeks after operation. The participants will wear a soft splint for six weeks.
Treatment:
Other: Early mobilisation after CMC1-surgery
Conservative treatment after CMC1-surgery
Other group
Description:
Current standard procedure: Mobilisation at six weeks after operation. The participants will wear a rigid splint for six weeks.
Treatment:
Other: Early mobilisation after CMC1-surgery

Trial contacts and locations

1

Loading...

Central trial contact

Tove Nilsen, MSc; Ingvild Kjeken, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems